Brief: Medexus Pharmaceuticals & Medac Conclude Negotiations To Amend Us Treosulfan Agreement
Dec 2 (Reuters) - Medexus Pharmaceuticals MDP.TO :
* MEDEXUS PHARMACEUTICALS: CO & MEDAC CONCLUDE NEGOTIATIONS
TO
AMEND US TREOSULFAN AGREEMENT
Source text: ID:
Further company coverage: MDP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million